Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy

Chemokines can induce chemotactic cell migration by interacting with G protein-coupled receptors to play a significant regulatory role in the development of cancer. CXC chemokine-12 (CXCL12) can specifically bind to CXC chemokine receptor 4 (CXCR4) and is closely associated with the progression of c...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Ruogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang, Bo Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Subjects:	CXCL12/CXCR4 axis chemokines cancer therapy nano-based drug delivery system
Online Access:	https://www.mdpi.com/1999-4923/14/8/1541

Similar Items

The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)

Does the Chemotherapy Protocol Affect CXCL12/CXCR4 Axes in Acute Myeloid Leukemia Patients with Monocytic Differentiation?
by: Bahar Yazdani, et al.
Published: (2022-01-01)

The effect of CXCL12 on survival outcomes of patients with viral hepatitis-associated hepatocellular carcinoma after hepatectomy
by: Yan Lu, et al.
Published: (2024-05-01)

Targeting the CXCR4/CXCL12 Axis in Cancer Therapy: Analysis of Recent Advances in the Development of Potential Anticancer Agents
by: Gerardina Smaldone, et al.
Published: (2025-03-01)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
by: Crescenzo D’Alterio, et al.
Published: (2022-10-01)

Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
by: Heinrich Eileen L, et al.
Published: (2012-04-01)

Interleukin-1 receptor antagonist inhibits metastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
by: Jiachi Ma, et al.
Published: (2021-12-01)

The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
by: Rojin Sarallah, et al.
Published: (2025-02-01)

Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01)

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
by: Zijian Pan, et al.
Published: (2022-03-01)

Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice
by: Lingjie Meng, et al.
Published: (2025-04-01)

The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
by: Michela Roberto, et al.
Published: (2023-03-01)

IS4‐FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells
by: Isabel Hamshaw, et al.
Published: (2024-10-01)

Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance
by: Yunfu Lv, et al.
Published: (2023-08-01)

CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
by: Wu Xia, et al.
Published: (2023-08-01)

Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
by: Jan-Hendrik Bockmann, et al.
Published: (2025-03-01)

CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
by: Seong-Kyu Kim, et al.
Published: (2023-02-01)

Advances in CXCR7 Modulators
by: Nicole Lounsbury
Published: (2020-02-01)

Association of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients
by: Saba Gharibi, et al.
Published: (2022-10-01)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
by: Jingjing Yu, et al.
Published: (2023-06-01)

Early pharmacological blockade of the CXCL12-CXCR4 axis attenuates vertebral hypercalcification in a zebrafish model of pseudoxanthoma elasticum
by: Jianjian Sun, et al.
Published: (2025-09-01)

The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer
by: Raquel Bodoque-Villar, et al.
Published: (2023-09-01)

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01)

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01)

The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration
by: Marco E. Bianchi, et al.
Published: (2020-08-01)

Blocking of the CXCR4-CXCL12 Interaction Inhibits the Migration of Chicken B Cells Into the Bursa of Fabricius
by: Maria Laparidou, et al.
Published: (2020-01-01)

The Role of Chemokine Receptor CXCR7 in Lung Cancer
by: Jun LIU, et al.
Published: (2010-12-01)

Involvement of chemokine CXCL12 and its receptor CXCR4 in uterine receptivity and potential relationship to fertility in cattle: a mini review
by: Michael J. D’Occhio, et al.
Published: (2025-08-01)

Extracellular Hsp70 Is Involved in the CXCL12/CXCR4 Pathway in Primary Human Nasal Epithelial Cells: A Preliminary Study
by: Seong Hee Kim, et al.
Published: (2023-11-01)

Elevated plasma CXCL12 leads to pain chronicity via positive feedback upregulation of CXCL12/CXCR4 axis in pain synapses
by: Shi-Ze Leng, et al.
Published: (2024-12-01)

Dose‐dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia
by: Will Camnitz, et al.
Published: (2012-12-01)

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
by: I. Aversa, et al.
Published: (2017-08-01)

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
by: Manoj K. Kashyap, et al.
Published: (2017-05-01)

Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway
by: Zelong Ma, et al.
Published: (2024-06-01)

CXCL16/CXCR6 Axis in Adipocytes Differentiated from Human Adipose Derived Mesenchymal Stem Cells Regulates Macrophage Polarization
by: Seung-Cheol Lee, et al.
Published: (2021-12-01)

The role of CXCL16 in atherosclerosis: from mechanisms to therapy
by: Yue Liu, et al.
Published: (2025-05-01)

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
by: Motyka J, et al.
Published: (2023-07-01)

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
by: Jack Y. Lee, et al.
Published: (2022-06-01)

LncRNA MALAT1 silencing represses CXCL12-induced proliferation, invasion, and homing behavior in multiple myeloma by inhibiting CXCR4
by: Jing Ning, et al.
Published: (2024-12-01)